Exelixis, Inc. (EXEL) | Stock Discussion Forums

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
Exelixis, Inc. (EXEL)

An SI Board Since January 2001

Posts	SubjectMarks	Bans	Symbol
930	66	0	EXEL

Emcee: kinkblot	Type: Unmoderated

Introduction Market Data Compact

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
55	Exelixis Files IND Application for Anticancer Compound XL999 Tuesday June 29, 6:	scaram(o)uche	-	6/29/2004
54	Exelixis Initiates Phase 3 Clinical Trial of XL119 in Bile Duct Cancer Wednesday	mopgcw	-	6/23/2004
53	At the Goldman Sachs Healthcare conference, Exelixis, NPS Pharmaceuticals, Renov	mopgcw	-	6/14/2004
52	That's not a research report, it's 10 minutes at a keyboard, regurgitati	scaram(o)uche	-	6/7/2004
51	Exelixis Initiates Phase 1 Trial for Anticancer Compound Xl647 Thursday June 3,	scaram(o)uche	-	6/3/2004
50	Thanks. And it seems MET, as in cMET, was spoken when I heard (and typed) METH.	keokalani'nui	-	5/9/2004
49	Curr Biol. 2002 Aug 20;12(16):1405-12. Analysis of a zebrafish VEGF receptor	scaram(o)uche	-	5/9/2004
48	Thanks for doing that! KDR is a VEGFr. (eom)	scaram(o)uche	-	5/9/2004
47	GS: EXEL (IL/N): Q1 better on lower expenses. Pipeline gaining momentum. 52-Wee	mopgcw	-	5/5/2004
46	So one year from now, this might be the clinical picture if all milestones are a	keokalani'nui	-	5/5/2004
45	Exelixis Announces First Quarter 2004 Financial Results SOUTH SAN FRANCISCO, Ca	nigel bates	-	5/4/2004
44	CIBC update. A few things moved up into the canned presentation: 1. Very exci	keokalani'nui	-	4/28/2004
43	GS report from Feb: EXEL (IL/N): Q4 better on lower expenses. Pipeline progress	mopgcw	-	3/30/2004
42	Exelixis Describes the Discovery of Novel Cancer Targets at AACR Monday March 29	keokalani'nui	-	3/29/2004
41	I called the company to ask if exel would have a presence at asco this year. No	keokalani'nui	-	3/17/2004
40	Exelixis Granted Orphan Drug Designation for Anticancer Agent XL119 Monday March	nigel bates	-	3/15/2004
39	SGC is worth listening to. The bmy targets may be the crown jewels?!? Good gr	keokalani'nui	-	3/9/2004
38	You caught me in an intra-15 minute edit, as you'll see if you look back. S	keokalani'nui	-	3/5/2004
37	Quertermous' lab discovered Del-1 before he moved to Stanford. It belonged	scaram(o)uche	-	3/5/2004
36	Circulation. 2004 Feb 23 [Epub ahead of print] Related Articles, Links Devel	keokalani'nui	-	3/5/2004
35	Exelixis Publishes World's Most Comprehensive Collection of Functional Gene	nigel bates	-	2/23/2004
34	Exelixis Files IND Application for Anticancer Agent XL647 SOUTH SAN FRANCISCO,	nigel bates	-	2/19/2004
33	Artemis Pharmaceuticals and Aventis Pharma R&D Sign Agreements Related to Mo	nigel bates	-	2/9/2004
32	Exelixis Showcases R&D Pipeline at JPMorgan Healthcare Conference Two New Cl	nigel bates	-	1/13/2004
31	I went to bed early.	nigel bates	-	12/18/2003

Go to reply# or date (mm/dd/yy):